Home > Applications > Inherited Disease

Inherited Disease

When timing is critical - speed counts

From sample to report - WGS or targeted, short-read or long-read, we can help you lift the veil on inherited disease status

Clinical inherited disease screening focuses on identifying genetic variations associated with hereditary disorders. These tests help diagnose inherited conditions, assess disease risk in individuals with a family history of the disorder, and facilitate genetic counselling. By pinpointing specific genetic abnormalities, clinicians can provide personalised management plans, including early detection, intervention, and family planning options. This testing plays a crucial role in improving patient care by enabling proactive measures to mitigate the impact of inherited diseases and enhance quality of life.

Decode Science can assist clinical inherited disease groups to improve their outcomes by working together on their entire workflow. From automation and sequencers, customised targeted sequencing panels and library prep, bespoke variant analysis, rare and difficult structural variant detection and more. At Decode Science, we pride ourselves on the level of flexibility, customisation, and collaboration we bring when working together to come up with a solution that improves outcomes for you and your patients.

High-efficiency guide RNAs for knockouts and knock-ins.
CRISPR experts agree that using synthetic single guide RNAs (sgRNAs) for genome engineering generate more efficient and consistent editing results than any other type of guide RNAs.
Synthego sgRNAs are highly pure guides that deliver indel frequencies of up to 99%, making it easy to efficiently conduct knockout or knock-ins in virtually any cell type. Their sgRNAs can be ordered with site-specific chemical modifications that provide greater stability and decreased activation of the cellular innate immune response.
Twist Bioscience

Twist Bioscience

Twist Bioscience, headquartered in South San Francisco, is a prominent biotechnology company specializing in the manufacture of synthetic DNA and DNA products for diverse industries. Established in 2013 by Emily Leproust, Bill Banyai, and Bill Peck, Twist Bioscience has quickly emerged as a leader in the field.

In March 2021, the company was represented by Emily Leproust at a tabletop exercise during the Munich Security Conference. The simulation focused on an outbreak of weaponized monkeypox, showcasing Twist Bioscience's involvement in addressing critical global challenges. In May 2021, Twist Bioscience collaborated with the Genome Project-Write to launch a groundbreaking Computer-Aided Design (CAD) platform for whole genome design. This innovative platform automates workflows, facilitating collaborative efforts essential for scaling up genome design—from designing plasmids to megabases across entire genomes. This initiative marks a significant advancement in genomic research and underscores Twist Bioscience's commitment to driving progress through technology and collaboration.




MGI, also known as MGI Tech, is a prominent Chinese biotechnology company specializing in a comprehensive array of products and technologies catering to the genetic sequencing, genotyping, gene expression, and proteomics markets. Headquartered in Shenzhen, China, MGI has established itself as a leading provider of innovative solutions to meet the evolving needs of the biotechnology and life sciences industries. With its diverse product line and cutting-edge technologies, MGI is dedicated to advancing research and applications in genomics and proteomics fields, contributing to scientific breakthroughs and advancements worldwide.


Genoox Logo


Genoox represents a unique fusion of geneticists, bioinformaticians, engineers, and technology experts collaborating to address a wide range of genomic inquiries through the collective power of community, data, and insights. At Genoox, the core objective is to decipher the massive volumes of genomic data generated daily and transform them into accessible, precise, and actionable insights at the point of care.



STOmics stands at the forefront of advancing spatially-resolved transcriptomic analysis through its revolutionary SpaTial Enhanced REsolution Omics-Sequencing (Stereo-seq) technology. Leveraging proprietary Stereo-seq technology, which is built on DNA Nanoball (DNB) technology, researchers gain access to a groundbreaking tool for exploring spatial biology with unparalleled field-of-view and resolution.

Stereo-seq operates in square-centimeter units, with the standard 1x1 cm RNA capture unit utilizing the STOmics-GeneExpression-S1 Chip. This innovative chip combines centimeter-scale field-of-view in situ capture of comprehensive transcriptome information with nanoscale resolution, resulting in unmatched quality of spatial transcriptomic analysis.



seqWell is on a mission to redefine NGS library preparation, unlocking the full potential of today's DNA sequencing instruments. At the heart of our innovation lies the plexWell™ platform, a groundbreaking library preparation technology that revolutionizes multiplexing by enabling simple and scalable processing of hundreds to thousands of samples without the need for time- and cost-consuming normalization steps.

The plexWell platform boasts a wide-ranging impact across various applications, including synthetic biology, targeted sequencing, single-cell analysis, and both low- and high-depth sequencing of human, plant, animal, and microbial genomes. By eliminating the complexities associated with traditional library preparation methods, plexWell empowers researchers to accelerate their sequencing workflows while maximizing throughput and efficiency.


Long Read Genomics


Bionano Laboratories is a leading provider of innovative testing solutions aimed at revolutionizing genetic testing applications for healthcare providers, researchers, and industry partners. With the commitment to advancing genomics, we continuously strive to introduce transformative technologies that drive progress in the field.

The state-of-the-art CLIA facility in San Diego, along with other facilities worldwide, positions us to deliver exceptional testing services characterized by accuracy, reliability, and efficiency. These cutting-edge capabilities enable us to uncover a broader spectrum of answers, empowering the customers to gain deeper insights into genetic variations and their implications for health and disease.


BiOptic White Logo


BiOptic Inc., established in 2004, specializes in biotechnology instrumentation for research and clinical use. It pioneers OEM/ODM solutions using Capillary Gel Electrophoresis (CGE) Technology globally. In 2009, it embarked on developing a novel CGE instrument with disposable gel cartridges, launching its patented Fragment Analyzer Qsep100 in 2011. Over 7 years, it expanded its product line to include Qsep1, Qsep400, and the Qampmini mini-PCR machine with innovative Direct-PCR reagent kits. BiOptic aims to lead the biotechnology industry by offering user-friendly, cost-effective CGE instruments and technical solutions to top institutions globally. With facilities in Taiwan, the US, and China, it serves customers in 50+ countries, known for advanced instrumentation, superior service, and extensive technical support. Committed to quality and value, BiOptic caters to life science research, clinical diagnostics, pharmaceuticals, food industries, and agricultural sectors.


Let’s Find You an Application That Helps Your Research

Get a call from your local Decode Science representative to help you find the best fit genomics products for you.